Coronary Artery Disease
Ann Arbor-based AlphaCore Pharma and Rockville, Md.-based Advanced Bioscience Laboratories Tuesday announced funding from the National Heart, Lung and Blood Institute, part of the National Institutes of Health, to manufacture a new treatment for a type of coronary artery disease that runs in families.
According to a report released by the Centers for Disease Control, the highest rates of self–reported coronary heart disease are among older adults aged 65 and over, and American Indians/Alaskan Natives.
Amid rising concern about the overuse of “big-ticket” medical technology, a study has revealed new information about the overuse of angioplasty procedures for those suffering from coronary artery disease.
An undergraduate design team from Michigan Technological University has at found a couple of new ways to replicate what happens to stents and other manmade things tucked inside our blood vessels.